Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report

Medicine (Baltimore). 2020 Jan;99(3):e18808. doi: 10.1097/MD.0000000000018808.

Abstract

Rationale: Malignant phyllodes tumors of the breast are rare, and there are currently no guidelines and a large number of clinical trials to guide the treatment of recurrence tumor. Here we reported a case of radiotherapy with apatinib for the treatment of recurrent malignant phyllodes tumor of the breast.

Patient concerns: A 58-year-old patient with massive breast mass was admitted to our hospital. Two months after surgical treatment, the tumor recurred in the chest wall scar.

Diagnoses: The histopathologic diagnoses was right breast malignant phyllodes tumor with chondrosarcomas and osteosarcomas in some areas.

Interventions: The patient was first treated with surgery. Malignant phyllodes tumor recurred in the chest wall two months after surgery and was treated with radiotherapy and apatinib.

Outcomes: With surgery, radiotherapy and apatinib treatment, the patient still died within several months.

Lessons: Apatinib and radiotherapy failed to obtain good therapeutic effect in the recurrence of breast malignant phyllodes tumor in this case.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Chemoradiotherapy*
  • Fatal Outcome
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Recurrence, Local / therapy*
  • Phyllodes Tumor / diagnostic imaging
  • Phyllodes Tumor / secondary
  • Phyllodes Tumor / therapy*
  • Pyridines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Pyridines
  • apatinib